Development of a single device to quantify motor impairments of the elbow: proof of concept.
Levinia Lara van der Velden, Bram Onneweer, Claudia Josephina Wilhelmina Haarman and 4 others
PMID 35864498WHAT IT FOUND
A robotic device measured elbow weakness, synergy, elasticity, and spasticity in ten stroke patients within one hour.
Every patient showed at least one impairment outside the healthy range. The device is feasible for quantifying these deficits, but it is not yet proven reliable or valid.
Key findings
01The device successfully quantified four specific elbow impairments (weakness, synergy, elasticity, spasticity) in a single session for all ten patients.
02All ten stroke patients had at least one impairment value that fell outside the reference range of the healthy controls.
03The total measurement time averaged 63 minutes, and patients reported low burden (1.8/10) and pain (1.3/10).
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This was a small pilot study with no hypothesis testing or statistical analysis of outcomes. The device requires patients to maintain an 80-degree shoulder abduction position, excluding those with severe pain or inability to hold the arm up. Reliability and validity of the device have not been established; it was compared to clinical scales but not against a gold standard. The study did not test the device's ability to detect changes over time (responsiveness) or its test-retest reliability.
Declared interests
The device was developed by Hankamp Rehab. The study was funded by Health~Holland.
The easy way to misread this
Do not interpret the radar charts as evidence that this device is a superior or validated assessment tool. The study was a feasibility test on ten patients without statistical analysis, so the device's accuracy and reliability are not yet proven.